Hostname: page-component-745bb68f8f-g4j75 Total loading time: 0 Render date: 2025-02-06T11:15:10.211Z Has data issue: false hasContentIssue false

Acute unilateral sensorineural hearing loss associated with anabolic steroids and polycythaemia: case report

Published online by Cambridge University Press:  14 December 2015

T Tikka*
Affiliation:
Department of ENT, Birmingham Heartlands (Teaching) Hospital, UK
N Mistry
Affiliation:
Department of ENT, Birmingham Heartlands (Teaching) Hospital, UK
A Janjua
Affiliation:
Department of ENT, Birmingham Heartlands (Teaching) Hospital, UK
*
Address for correspondence: Miss Theofano Tikka, ENT Department, Birmingham Heartlands Hospital, Birmingham B9 5SS, UK E-mail: Theofano.tikka@gmail.com
Rights & Permissions [Opens in a new window]

Abstract

Background:

Unilateral sudden sensorineural hearing loss due to an infarct in the vertebrobasilar system has been widely reported. Most patients have a background of traditional coronary risk factors related to these cerebrovascular episodes.

Case report:

A 32-year-old male, a regular user of anabolic steroids, presented to the emergency department with unilateral sensorineural hearing loss and symptoms suggestive of an infarct of the anterior inferior cerebellar artery but in the absence of risk factors for ischaemic stroke.

Results:

Magnetic resonance imaging confirmed the presence of infarction in the region supplied by the anterior inferior cerebellar artery. Polycythaemia was found on haematological analysis, which we believe was secondary to the use of anabolic steroids. The patient was commenced on aspirin as per the stroke management protocol. There was resolution of neurological symptomatology six weeks after the episode, but no improvement in hearing.

Conclusion:

To our knowledge, this is the first case report of unilateral sensorineural hearing loss secondary to the use of anabolic steroids causing polycythaemia. This cause should be considered in the differential diagnosis of patients presenting with sensorineural hearing loss, especially in young males, when no other risk factors can be identified.

Type
Clinical Records
Copyright
Copyright © JLO (1984) Limited 2015 

Introduction

Sudden unilateral or bilateral sensorineural hearing loss due to infarcts of the anterior inferior cerebellar artery,Reference Lee, Whitman, Lim, Lee and Park1Reference Hausler and Levine8 posterior inferior cerebellar arteryReference Lee9, Reference Lee and Yoon10 or basilar arteryReference Muttikkal, Kesser and Mukherjee11Reference Lee and Baloh13 have previously been reported in the literature. The majority of cases involve elderly patients with a past medical history of a cerebral infarct, arrhythmia, hypertension or diabetes, predisposing them to a cerebrovascular event. To the best of our knowledge, no cases of unilateral sensorineural hearing loss due to a cerebellar infarct in young, fit and well patients have been described. We report a case of sensorineural hearing loss in a young male with no traditional cardiovascular risk factors but with known misuse of anabolic steroids.

Case report

A 32-year-old male visited our accident and emergency department complaining of a 6-hour onset of dizziness, unsteadiness, nausea, headache and reduced hearing in his right ear. He also reported blurred vision and photophobia. He was otherwise fit and well, working full-time in a gym and powerlifting as a hobby. He was a non-smoker, with no significant medical history. On direct questioning, he admitted that he had taken anabolic steroids at regular intervals for the last three years (testosterone enanthate, Oral Turinabol and oxymetholone).

On examination, the patient was cardiovascularly stable, with a Glasgow coma scale score of 15. His pupils were equal and reactive to light. Initial cranial nerve examination findings were normal. Further neurological examination showed normal tone, power, reflexes, co-ordination and sensation in all four limbs.

The patient was admitted to the acute medical unit with a working diagnosis of subarachnoid haemorrhage. He underwent an unenhanced computed tomography scan, which ruled out the presence of intracranial haemorrhage or a space-occupying lesion. The cerebral parenchyma, ventricles and basal cisterns were also found to be normal. He underwent a lumbar puncture, with normal findings. Blood tests revealed an elevated white blood cell level of 13.85 × 109 per litre and a high red blood cell count of 6.63 × 1012 per litre. His haemoglobin value was also raised to 18.2 gm/dl. The remaining blood parameters, including clotting, renal and liver function, were unremarkable. He was kept in hospital overnight for observation and given analgesics to treat the headache, with a working diagnosis of migraine.

The next morning, the patient complained of complete right-sided deafness and tinnitus, with increased unsteadiness. As a result, an urgent ENT opinion was sought. ENT examination revealed intact ear drums bilaterally, with normal ear canals. The tuning fork tests showed Weber's test lateralising to the left side and a positive Rinne test on the left ear. On the right side, the patient could not detect any sound via air conduction on tuning fork testing. Grade 1 horizontal nystagmus was detected on leftward gaze. Repeat examination of the remaining cranial nerve was unremarkable. Neurological assessments for ataxia, Romberg's sign and dysmetria were negative. A working diagnosis of lateral pontine syndrome was made in light of interrupted blood supply of the anterior inferior cerebellar artery.

An urgent magnetic resonance imaging scan of the brain and brain stem showed a well-defined focal area of signal change involving the inferior aspect of the right cerebellar hemisphere that exhibited diffusion restriction (Figure 1). The occlusion was in the region of the right anterior inferior cerebellar artery, in keeping with an acute anterior inferior cerebellar artery infarction. There was no evidence of haemorrhage. The remainder of the brain and brain stem was normal, with patent basilar arteries.

FIG. 1 Axial, T2-weighted magnetic resonance imaging scans of the patient (a & b), which show a diffuse high signal intensity in the region of the right anterior inferior cerebellar artery, suggesting acute infarction.

The pure tone audiogram showed hearing within normal limits on the left ear, and a profound hearing loss on the right side with no response to the limit of the equipment with air conduction (Figure 2). Unmasked bone conduction was within normal limits. Findings were consistent with a right sensorineural hearing loss due to a right anterior inferior cerebellar artery infarct.

FIG. 2 Pure tone audiogram of the patient (a, right ear; b, left ear), showing profound sensorineural hearing loss in the right ear (a) on day 1 following acute presentation with hearing loss.  = Bone conduction (unmasked) right ear; • = air conduction (masked) right ear; [ = bone conduction (masked) right ear; ↙ = no detectable sound; ○ = air conduction (unmasked) right ear; AC = air conduction; BC = bone conduction; ×  = air conduction (unmasked) left ear.

The patient was commenced on antiplatelet medications in the form of 300 mg aspirin daily for two weeks, followed by clopidogrel 75 mg daily. He was also started on simvastatin 40 mg once per day and was advised to stop taking the anabolic steroids.

The patient was followed up six weeks after the initial onset of symptoms. He was not complaining of dizziness anymore, but he reported occasional tinnitus in the right ear. On examination, he had no nystagmus. His blood test results were normal. A follow-up pure tone audiogram did not show any improvement in thresholds in the right ear (Figure 3).

FIG. 3 Pure tone audiogram of the patient (a, right ear; b, left ear), showing no improvement in right-sided hearing loss six weeks following the acute presentation, after antiplatelet treatment.  = Bone conduction (unmasked) right ear; • = air conduction (masked) right ear; [ = bone conduction (masked) right ear; ↙ = no detectable sound; ○ = air conduction (unmasked) right ear; AC = air conduction; BC = bone conduction; ×  = air conduction (unmasked) left ear.

Discussion

Many theories have been proposed to explain the mechanism of sensorineural hearing loss, although its cause remains unknown in the majority of cases.Reference Screiber, Agrup, Haskart and Luxon14 Inflammation, most commonly due to a viral infection or ischaemia of the vertebrobasilar system due to circulatory compromise, is the most well known cause.Reference Screiber, Agrup, Haskart and Luxon14Reference Mosnier, Stepanian, Baron, Bodenez, Robier and Meyer18

The main blood supply to the inner ear originates from terminal branches of the anterior inferior cerebellar artery, and in a small proportion of the population it originates from the posterior inferior cerebellar artery or directly from the basilar artery.Reference Flint, Haughey, Lund, Niparko, Richardson and Robbins19 Many cases have been reported of isolated infarctions of these arteries resulting in unilateral sensorineural hearing loss. Lee and Yoon reported two patients who developed sensorineural hearing loss. Both patients had a background of atrial fibrillation, and the cause of their hearing loss was attributed to small emboli causing isolated infarctions of the posterior inferior cerebellar artery.Reference Lee and Yoon10 Muttikkal et al.Reference Muttikkal, Kesser and Mukherjee11 presented a patient with hearing loss after an infarct of the lateral lemniscus, and Martines et al.Reference Martines, Dispenza, Gagliardo, Martines and Bentivegna5 identified a patient with sensorineural hearing loss after an infarct of the anterior inferior cerebellar artery. In both cases, the patients’ medical history included all the traditional cardiovascular risk factors of a cerebrovascular accident. The same pattern was found in all case reports of cerebellar infarcts linked with sensorineural hearing loss.Reference Lee, Whitman, Lim, Lee and Park1Reference Lee and Baloh13 A recent systematic review and meta-analysis confirmed that acquired and inherited cardiovascular risk factors are associated with an increased risk of sensorineural hearing loss.Reference Lin, Krall, Westerberg, Chadha and Chau20

We present a case of sudden hearing impairment secondary to polycythaemia in a patient taking anabolic steroids with no independent risk factors currently linked with sensorineural hearing loss. It is known that anabolic steroids induce polycythaemia by increasing the production of erythropoietin of the stem cells on the bone marrow.Reference Kopera21Reference Viallard, Marit, Mercie, Leng, Reiffers and Pellegrin23 In this case, the patient had been using a combination of testosterone enanthate, Oral Turinabol and oxymetholone at regular intervals over the previous three years. The erythrogenic effect of testosterone propionate and nandrolone caproate, androstanolone, oxymetholone, nandrolone phenylpropionate, and nandrolone decanoate have been confirmed in in vivo studies in polycythaemic mice. Increased erythropoiesis was measured by the incorporation of 59Fe (iron) into newly formed red cells.Reference Bozzini and Alippi24 Further comparative studies have confirmed the positive erythropoietic effect of androgenic and anabolic steroids.Reference Gorshein, Murphy and Gardner25 Androgenic steroids – in particular oxymetholone – have been used in the treatment of anaplastic anaemia. Low-Beer and Scott described a case of symptomatic polycythaemia following treatment of anaplastic anaemia with oxymetholone.Reference Low-Beer and Scott26 Whenever oxymetholone was discontinued, relapse of pancytopenia was observed.

The use of anabolic steroids has increased over the last three decades, despite evidence of their adverse effects. There are published case reports and small case–control studies that describe patients previously fit and well who presented with acute myocardial infarction and polycythaemia attributed to anabolic steroid use.Reference Stergiopoulos, Brennan, Mathews, Setaro and Kort27Reference Nieminen, Rämö, Viitasalo, Heikkilä, Karjalainen and Mäntysaari32 In a previous case, a cerebral infarct causing a sensorimotor transient ischaemic attack was attributed to anabolic steroid use in a 40-year-old male weightlifter who had no other significant past medical history.Reference Harston, Batt, Fan, Okell, Sheerin and Littlewood33 As in our case, the patient had increased haemoglobin levels and red blood cell count, causing an aggregation of red blood cells and an increase in blood viscosity, resulting in a focal impairment of cerebral function. A transcranial Doppler examination revealed a global reduction in flow velocities.Reference Harston, Batt, Fan, Okell, Sheerin and Littlewood33

  • Unilateral sudden sensorineural hearing loss due to cerebral infarction has been described in the literature

  • Traditional coronary risk factors are related to these cerebrovascular episodes

  • This paper described a case of sensorineural hearing loss secondary to anabolic steroid use causing polycythaemia

  • Misuse of anabolic steroids should be considered in the differential diagnosis of sensorineural hearing loss

Doctors working in the emergency department, general practitioners and ENT doctors should be aware of the link between anabolic steroids and polycythaemia, which on rare occasions might manifest with a cerebral infarct affecting hearing. This should be especially suspected in young male individuals with no other cardiovascular risk factors. Including a question about the use of anabolic steroids in such patients who present with sensorineural hearing loss could help in attaining a prompt working diagnosis of a cerebellar infarct affecting hearing. In our case, the correct diagnosis was made almost 24 hours after initial presentation of the patient to the emergency department, resulting in a delay of starting the appropriate treatment. Cerebral infarct secondary to anabolic steroid use should be considered in the differential diagnosis of sensorineural hearing loss.

Conclusion

We observed a case of sudden unilateral sensorineural hearing loss due to an infarct of the anterior inferior cerebellar artery in a young male with no known risk factors predisposing him to a stroke. A link between the use of anabolic steroids and cerebellar infarct was made. Doctors should be aware of the possible association between anabolic steroids and cerebral infarcts when assessing young patients presenting with acute unilateral sensorineural hearing loss and include it in their differential diagnosis.

References

1Lee, H, Whitman, GT, Lim, JG, Lee, SD, Park, YC. Bilateral sudden deafness as a prodrome of anterior inferior cerebellar artery infarction. Arch Neurol 2001;58:1287–9CrossRefGoogle ScholarPubMed
2Lee, H, Sohn, SI, Jung, DK, Cho, YW, Lim, JG, Yi, SD et al. Sudden deafness and anterior inferior cerebellar artery infarction. Stroke 2002;33:2807–12CrossRefGoogle ScholarPubMed
3Oas, JG, Baloh, RW. Vertigo and the anterior inferior cerebellar artery syndrome. Neurology 1992;42:2274–9CrossRefGoogle ScholarPubMed
4Lee, H, Kim, JS, Chung, EJ, Yi, HA, Chung, IS, Lee, SR et al. Infarction in the territory of anterior inferior cerebellar artery: spectrum of audiovestibular loss. Stroke 2009;40:3745–51CrossRefGoogle ScholarPubMed
5Martines, F, Dispenza, F, Gagliardo, C, Martines, E, Bentivegna, D. Sudden sensorineural hearing loss as prodromal symptom of anterior inferior cerebellar artery infarction. ORL J Otorhinolaryngol Relat Spec 2011;73:137–40CrossRefGoogle ScholarPubMed
6Ikegami-Takada, T, Izumikawa, M, Doi, T, Takada, Y, Tomoda, K. AICA syndrome with facial palsy following vertigo and acute sensorineural hearing loss. Auris Nasus Larynx 2012;39:244–8CrossRefGoogle ScholarPubMed
7Lee, H. Audiovestibular loss in anterior inferior cerebellar artery territory infarction: a window to early detection? J Neurol Sci 2012;313:153–9CrossRefGoogle ScholarPubMed
8Hausler, R, Levine, R. Auditory dysfunction in stroke. Acta Otolaryngol 2000;120:689703Google ScholarPubMed
9Lee, H. Sudden deafness related to posterior circulation infarction in the territory of the nonanterior inferior cerebellar artery: frequency, origin, and vascular topographic pattern. Eur Neurol 2008;59:302–6CrossRefGoogle Scholar
10Lee, EJ, Yoon, YJ. Sudden deafness as an initial presenting symptom of posterior inferior cerebellar artery infarction: two case reports. J Laryngol Otol 2014;128:1011–14CrossRefGoogle ScholarPubMed
11Muttikkal, TJ, Kesser, BW, Mukherjee, S. Isolated contralateral sudden sensorineural hearing loss: an unusual manifestation of pontine infarct. Neuroradiol J 2014;27:483–6CrossRefGoogle ScholarPubMed
12Doyle, KJ, Fowler, C, Starr, A. Audiological findings in unilateral deafness resulting from contralateral pontine infarct. Otolaryngol Head Neck Surg 1996;114:482–6CrossRefGoogle ScholarPubMed
13Lee, H, Baloh, RW. Sudden deafness in vertebrobasilar ischemia: clinical features, vascular topographical patterns and long-term outcome. J Neurol Sci 2005;228:99104CrossRefGoogle ScholarPubMed
14Screiber, BE, Agrup, C, Haskart, DO, Luxon, LM. Sudden sensorineural hearing loss. Lancet 2010;375:1203–11CrossRefGoogle Scholar
15Cecchi, E, Mannini, L, Abbate, R. Role of hyperviscosity in cardiovascular and microvascular diseases [in Italian]. G Ital Nefrol 2009;26(suppl 46):20–9Google ScholarPubMed
16Capaccio, P, Pignataro, L, Gaini, LM, Sigismund, PE, Novembrino, C, De Giuseppe, R et al. Unbalanced oxidative status in idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2012;269:449–53CrossRefGoogle ScholarPubMed
17Rudack, C, Langer, C, Stoll, W, Rust, S, Walter, M. Vascular risk factors in sudden hearing loss. Thromb Haemost 2006;95:454–61CrossRefGoogle ScholarPubMed
18Mosnier, I, Stepanian, A, Baron, G, Bodenez, C, Robier, A, Meyer, B et al. Cardiovascular and thromboembolic risk factors in idiopathic sudden sensorineural hearing loss: a case-control study. Audiol Neurootol 2011;16:5566CrossRefGoogle ScholarPubMed
19Flint, PW, Haughey, BH, Lund, VJ, Niparko, JK, Richardson, MA, Robbins, KT et al. Cummings Otolaryngology – Head and Neck Surgery, 5th edn.Philadelphia: Mosby Elsevier, 2010Google Scholar
20Lin, RJ, Krall, R, Westerberg, BD, Chadha, NK, Chau, JK. Systematic review and meta-analysis of the risk factors for sudden sensorineural hearing loss in adults. Laryngoscope 2012;122:624–35CrossRefGoogle ScholarPubMed
21Kopera, H. Side effects of anabolic steroids and contraindications. Wien Med Wochenschr 1993;143:399400Google ScholarPubMed
22Verwilghen, R, Louwagie, A, Waes, J, Vandenbroucke, J. Anabolic agents and relative polycythaemia. Br J Haematol 1966;12:712–16CrossRefGoogle ScholarPubMed
23Viallard, JF, Marit, G, Mercie, P, Leng, B, Reiffers, J, Pellegrin, JL. Polycythaemia as a complication of transdermal testosterone therapy. Br J Haematol 2000;110:237–8CrossRefGoogle ScholarPubMed
24Bozzini, CE, Alippi, RM. The erythrogenic effect of steroids with predominant anabolic or androgenic activity in the polycythemic mouse. Horm Metab Res 1971;3:52–4CrossRefGoogle ScholarPubMed
25Gorshein, D, Murphy, S, Gardner, FH. Comparative study on the erythropoietic effect of androgens and their mode of action. J Appl Physiol 1973;35:276–8CrossRefGoogle ScholarPubMed
26Low-Beer, TS, Scott, GS. Polycythaemia in androgen-dependent anaplastic anaemia. Br Med J 1976;1:197–8CrossRefGoogle Scholar
27Stergiopoulos, K, Brennan, JJ, Mathews, R, Setaro, JF, Kort, S. Anabolic steroids, acute myocardial infarction and polycythemia: a case report and review of the literature. Vasc Health Risk Manag 2008;4:1475–80CrossRefGoogle ScholarPubMed
28Kennedy, MC, Lawrence, C. Anabolic steroid abuse and cardiac death. Med J Aust 1993;158:346–8CrossRefGoogle ScholarPubMed
29McNutt, RA, Ferenchick, GS, Kirlin, PC, Hamlin, NJ. Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids. Am J Cardiol 1988;62:164CrossRefGoogle Scholar
30McCarthy, K, Tang, AT, Dalrymple-Hay, MJ, Haw, MP. Ventricular thrombosis and systemic embolism in bodybuilders: etiology and management. Ann Thorac Surg 2000;70:658–60CrossRefGoogle ScholarPubMed
31Mewis, C, Spyridopoulos, I, Kühlkamp, V, Seipel, L. Manifestation of severe coronary heart disease after anabolic drug abuse. Clin Cardiol 1996;19:153–5CrossRefGoogle ScholarPubMed
32Nieminen, MS, Rämö, MP, Viitasalo, M, Heikkilä, P, Karjalainen, J, Mäntysaari, M et al. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur Heart J 1996;17:1576–83CrossRefGoogle ScholarPubMed
33Harston, GW, Batt, F, Fan, L, Okell, TW, Sheerin, F, Littlewood, T et al. Lacunar infarction associated with anabolic steroids and polycythemia: a case report. Case Rep Neurol 2014;6:34–7CrossRefGoogle ScholarPubMed
Figure 0

FIG. 1 Axial, T2-weighted magnetic resonance imaging scans of the patient (a & b), which show a diffuse high signal intensity in the region of the right anterior inferior cerebellar artery, suggesting acute infarction.

Figure 1

FIG. 2 Pure tone audiogram of the patient (a, right ear; b, left ear), showing profound sensorineural hearing loss in the right ear (a) on day 1 following acute presentation with hearing loss.  = Bone conduction (unmasked) right ear; • = air conduction (masked) right ear; [ = bone conduction (masked) right ear; ↙ = no detectable sound; ○ = air conduction (unmasked) right ear; AC = air conduction; BC = bone conduction; ×  = air conduction (unmasked) left ear.

Figure 2

FIG. 3 Pure tone audiogram of the patient (a, right ear; b, left ear), showing no improvement in right-sided hearing loss six weeks following the acute presentation, after antiplatelet treatment.  = Bone conduction (unmasked) right ear; • = air conduction (masked) right ear; [ = bone conduction (masked) right ear; ↙ = no detectable sound; ○ = air conduction (unmasked) right ear; AC = air conduction; BC = bone conduction; ×  = air conduction (unmasked) left ear.